Form 4/A for SPRY ARS Pharmaceuticals, Inc.
Accepted 2022-02-24 00:00:00 ET · period of report 2020-12-08 · accession 0001209191-22-012878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-02-24 | 2020-12-08 | SPRY | Hawkinson Russ | Sr. VP of Fin | P - Purchase | $21.00 | +200 | 200 | New | +$4,200 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2020-12-08 | P | A | 200 | $21.00 | 200 | D | — | — | (F2) On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock. |